ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Oral Abstract Session

Clinical Trials and Related Studies to Improve CKD Outcomes

October 23, 2020 | 05:00 PM - 07:00 PM

Location: Simulive

Session Description

Oral Abstract Session

Learning Pathway(s)

  • Chronic Kidney Disease

Moderators

  • Titilayo O. Ilori, MBBS, MS
  • Julia J. Scialla, MD, FASN

Presentations

  • Association of Use of Kidney Disease Education Benefit with ESKD-Related Outcomes
    05:00 PM - 07:00 PM
    Kirsten L. Johansen, MD, FASN 
  • Correlation Between Patient Activation and Quality of Life Among Patients with CKD
    05:00 PM - 07:00 PM
    Mujahed Maher Issa Dauleh, MD
  • Breath Ammonia Is a Useful Biomarker Predicting Kidney Function in CKD Patients
    05:00 PM - 07:00 PM
    Ya-chung Tian, MD, PhD 
  • Estimated Glomerular Filtration Rate Equations: Do We Need to Use the Ethnicity Correction Factor in People of African Ancestry Outside of the United States?
    05:00 PM - 07:00 PM
    Rouvick Gama, MBChB
  • Mechanism of Higher Incidence of ESKD Among Blacks and Hispanics vs. Whites in the United States
    05:00 PM - 07:00 PM
    Guofen Yan, PhD 
  • Incidence of CKD and Environmental Inequities: An Integration of Ecological and Spatial Approaches in US Veterans
    05:00 PM - 07:00 PM
    Yun Han 
  • Chlorthalidone and Bumetanide in Advanced CKD: HEBE Trial
    05:00 PM - 07:00 PM
    Fabio Solis-Jimenez, MD, MS 
  • Benefits of Icosapent Ethyl Across a Range of Baseline Renal Function in Patients with Established Cardiovascular Disease or Diabetes: Results of REDUCE-IT RENAL
    05:00 PM - 07:00 PM
    Arjun Majithia, MD
  • Dapagliflozin Reduces the Risk of Hyperkalaemia in Patients with Heart Failure and Reduced Ejection Fraction: A Secondary Analysis from DAPA-HF
    05:00 PM - 07:00 PM
    Søren Lund Kristensen, MD, PhD
  • Metformin Improves Vascular Function in CKD Patients with Metabolic Syndrome
    05:00 PM - 07:00 PM
    Everly Ramos, MD